Ginkgo Bioworks Holdings (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 38,230 | 43,847 | 89,046 | 56,206 | 37,944 |
| Cost of Goods | 4,090 | 9,622 | 12,003 | 13,721 | 9,202 |
| Gross Profit | 34,140 | 34,225 | 77,043 | 42,485 | 28,742 |
| Operating Expenses | 115,202 | 138,453 | 132,250 | 266,151 | 206,946 |
| Operating Income | -80,972 | -103,606 | -55,204 | -222,945 | -178,002 |
| Other Income | -2,250 | -4,253 | -1,574 | 5,954 | 12,122 |
| Pre-tax Income | -83,222 | -107,859 | -56,778 | -216,991 | -165,880 |
| Income Tax | 88 | -325 | -375 | 190 | 31 |
| Net Income Continuous | -83,310 | -107,534 | -56,403 | -217,181 | -165,911 |
| Net Income Discontinuous | -7,647 | N/A | N/A | N/A | N/A |
| Net Income | $-90,957 | $-107,534 | $-56,403 | $-217,181 | $-165,911 |
| EPS Basic Total Ops | -1.68 | -1.92 | -1.08 | -4.23 | -3.31 |
| EPS Basic Continuous Ops | -1.54 | -1.92 | -1.08 | -4.23 | -3.31 |
| EPS Basic Discontinuous Ops | -0.14 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -1.68 | -1.91 | -1.08 | -4.23 | -3.32 |
| EPS Diluted Continuous Ops | -1.54 | -1.92 | -1.08 | -4.23 | -3.31 |
| EPS Diluted Discontinuous Ops | -0.14 | N/A | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -1.58 | -1.82 | -1.08 | -3.20 | N/A |
| EBITDA(a) | $-66,150 | $-87,954 | $-38,035 | $-157,757 | $-165,133 |